Cancer
October 22, 2025
ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
November 4, 2017
September 6, 2017
July 6, 2017
June 21, 2017
April 11, 2017
April 4, 2017
December 27, 2016
December 12, 2016
November 10, 2016
September 27, 2016
August 2, 2016
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community